Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women

Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):55-9. doi: 10.1016/j.ejogrb.2003.10.033.

Abstract

Objective: To investigate the mechanism by which exogenous oestrogen influences the homocysteine metabolism in postmenopausal women.

Study design: A randomized placebo controlled trial in which a methionine-loading test was performed, in 25 healthy postmenopausal women, before and after a 12-week oral treatment with placebo or daily 4 mg 17beta-estradiol with (HRT) or without (ERT) 10 mg dydrogesterone. Fasting and post-load homocysteine as well as Vitamins B(6), B(12) and folate were determined.

Results: In both treatment groups a significant 12% decrease in fasting homocysteine was observed. This decrease was accompanied by a post-load homocysteine increase of more than 20%. Vitamin B(6) values were decreased by more than 25%.

Conclusion: The hormone therapy induced lowering of fasting homocysteine and Vitamin B(6) levels and an increase in post-load homocysteine, supporting the hypothesis that homocysteine-methionine metabolism is modulated by hormone therapy in postmenopausal women.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Blood Chemical Analysis
  • Double-Blind Method
  • Dydrogesterone / administration & dosage*
  • Estradiol / administration & dosage*
  • Estrogen Replacement Therapy*
  • Female
  • Folic Acid / blood
  • Homocysteine / blood*
  • Humans
  • Methionine / administration & dosage*
  • Middle Aged
  • Postmenopause / blood*
  • Pyridoxine / blood
  • Treatment Outcome
  • Vitamin B 12 / blood

Substances

  • Homocysteine
  • Estradiol
  • Dydrogesterone
  • Folic Acid
  • Methionine
  • Pyridoxine
  • Vitamin B 12